Iris E. Eder

3.8k total citations
72 papers, 3.0k citations indexed

About

Iris E. Eder is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Iris E. Eder has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 31 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Iris E. Eder's work include Prostate Cancer Treatment and Research (35 papers), Hormonal and reproductive studies (12 papers) and Cancer, Lipids, and Metabolism (10 papers). Iris E. Eder is often cited by papers focused on Prostate Cancer Treatment and Research (35 papers), Hormonal and reproductive studies (12 papers) and Cancer, Lipids, and Metabolism (10 papers). Iris E. Eder collaborates with scholars based in Austria, Germany and United States. Iris E. Eder's co-authors include Helmut Klocker, Zoran Čulig, Georg Bartsch, Thomas Pütz, Alfred Hobisch, Georg Bartsch, Claudia Nessler‐Menardi, G. Bartsch, Wolfgang Horninger and Hannes Neuwirt and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Iris E. Eder

70 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Iris E. Eder 1.5k 1.4k 728 623 583 72 3.0k
Robert A. Sikes 1.3k 0.9× 1.6k 1.2× 608 0.8× 956 1.5× 385 0.7× 71 3.3k
Jacek Pinski 1.1k 0.8× 1.1k 0.8× 415 0.6× 727 1.2× 292 0.5× 114 2.9k
Jonathan M. Kurie 1.2k 0.8× 2.2k 1.6× 1.2k 1.6× 1.6k 2.5× 244 0.4× 73 4.0k
Susan S. Leong 1.1k 0.7× 1.4k 1.0× 395 0.5× 627 1.0× 469 0.8× 26 2.9k
Nora M. Navone 2.3k 1.6× 2.8k 2.1× 1.2k 1.7× 1.8k 2.8× 578 1.0× 136 5.4k
Marcus V. Cronauer 2.3k 1.6× 1.7k 1.3× 779 1.1× 698 1.1× 745 1.3× 73 3.8k
Paula Martikainen 852 0.6× 1.1k 0.8× 414 0.6× 432 0.7× 326 0.6× 44 2.3k
Meiju Ji 388 0.3× 2.1k 1.5× 685 0.9× 784 1.3× 341 0.6× 116 3.5k
Elzbieta Kawinski 886 0.6× 941 0.7× 305 0.4× 369 0.6× 321 0.6× 14 2.0k
Junichi Inokuchi 1.0k 0.7× 1.1k 0.8× 533 0.7× 478 0.8× 202 0.3× 161 2.4k

Countries citing papers authored by Iris E. Eder

Since Specialization
Citations

This map shows the geographic impact of Iris E. Eder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris E. Eder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris E. Eder more than expected).

Fields of papers citing papers by Iris E. Eder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris E. Eder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris E. Eder. The network helps show where Iris E. Eder may publish in the future.

Co-authorship network of co-authors of Iris E. Eder

This figure shows the co-authorship network connecting the top 25 collaborators of Iris E. Eder. A scholar is included among the top collaborators of Iris E. Eder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris E. Eder. Iris E. Eder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morales, Elisa, Martin Puhr, Sven Wach, et al.. (2024). MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer. Endocrinology. 165(10). 4 indexed citations
2.
Neuwirt, Hannes, Iris E. Eder, Philipp Gauckler, et al.. (2024). Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students – an interventional study. BMC Medical Education. 24(1). 179–179. 2 indexed citations
3.
Jáné, Eduard, Štefánia Hrončeková, Karl‐Dietrich Sievert, et al.. (2024). Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study. PLoS ONE. 19(3). e0300430–e0300430. 6 indexed citations
4.
Eder, Iris E., et al.. (2020). Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(11). 801–815. 8 indexed citations
5.
Puhr, Martin, Julia Hoefer, Andrea Eigentler, et al.. (2017). The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. Clinical Cancer Research. 24(4). 927–938. 129 indexed citations
6.
Eder, Iris E., et al.. (2017). 3D Hanging Drop Culture to Establish Prostate Cancer Organoids. Methods in molecular biology. 1612. 167–175. 32 indexed citations
7.
Hoefer, Julia, Johann Kern, Iris E. Eder, et al.. (2013). SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. Endocrine Related Cancer. 21(2). 175–187. 41 indexed citations
8.
Neuwirt, Hannes, Iris E. Eder, Martin Puhr, & Michael Rudnicki. (2012). SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner. Laboratory Investigation. 93(1). 123–134. 11 indexed citations
9.
Yang, Lin, et al.. (2011). Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells. Urology. 77(6). 1508.e1–1508.e7. 25 indexed citations
10.
Massoner, Petra, et al.. (2010). Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer. British Journal of Cancer. 103(10). 1479–1484. 51 indexed citations
11.
Schäfer, Georg, et al.. (2009). Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP‐dependent protein kinase A. International Journal of Cancer. 126(3). 775–789. 19 indexed citations
12.
Klocker, Helmut, Petra Hååg, Iris E. Eder, & Georg Bartsch. (2005). Targeting the androgen receptor in hormone-refractory prostate cancer ? new concepts. Future Oncology. 1(1). 93–101. 17 indexed citations
13.
Bektić, Jasmin, Roman Guggenberger, Iris E. Eder, et al.. (2005). Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer. PubMed. 4(2). 124–129. 44 indexed citations
14.
Hååg, Petra, Jasmin Bektić, Georg Bartsch, Helmut Klocker, & Iris E. Eder. (2005). Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 96(3-4). 251–258. 112 indexed citations
15.
Eder, Iris E., Thomas Pütz, Reinhold Ramoner, et al.. (2003). Long‐term androgen‐ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. The Prostate. 58(3). 259–268. 82 indexed citations
16.
Eder, Iris E., Zoran Čulig, Thomas Pütz, et al.. (2001). Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic. European Urology. 40(3). 241–251. 97 indexed citations
17.
Stenzl, Arnulf, Hannes Strasser, G. Klima, et al.. (2000). Reconstruction of the lower urinary tract using autologous muscle transfer and cell seeding: current status and future perspectives. World Journal of Urology. 18(1). 44–50. 11 indexed citations
18.
Eder, Iris E., Stefan Corvin, Marcus V. Cronauer, et al.. (2000). Selective culture conditions for different types of primary human bladder cells. World Journal of Urology. 18(5). 371–375. 7 indexed citations
19.
Eder, Iris E., Zoran Čulig, Reinhold Ramoner, et al.. (2000). Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Therapy. 7(7). 997–1007. 128 indexed citations
20.
Čulig, Zoran, Alfred Hobisch, Manfred Herold, et al.. (1998). Interleukin 1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells. British Journal of Cancer. 78(8). 1004–1011. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Sikes Breakdown of academic impact, for papers by Jacek Pinski Breakdown of academic impact, for papers by Jonathan M. Kurie Breakdown of academic impact, for papers by Susan S. Leong Breakdown of academic impact, for papers by Nora M. Navone Breakdown of academic impact, for papers by Marcus V. Cronauer Breakdown of academic impact, for papers by Paula Martikainen Breakdown of academic impact, for papers by Meiju Ji Breakdown of academic impact, for papers by Elzbieta Kawinski Breakdown of academic impact, for papers by Junichi Inokuchi
Rankless by CCL
2026